-transparent.png){kind=logo}
Primary hyperlipoproteinemias are of great interest for the physician and searcher, because of their atherogenic properties; on the other hand, a new type of hyperlipoproteinemia, namely hyperalphaliproproteinemia, seems to be a protective factor against clinical complications of atherosclerosis. The clinical, biological and pathophysiologic aspects of these diseases are studied both from the author's experience and literature data.
Related Publications
R Bakir, and
B Chanu, and
J Rouffy
January 1992,
Der Internist,
R Bakir, and
B Chanu, and
J Rouffy
January 1973,
Advances in experimental medicine and biology,
R Bakir, and
B Chanu, and
J Rouffy
September 1971,
Das Deutsche Gesundheitswesen,
R Bakir, and
B Chanu, and
J Rouffy
April 1983,
Pathologie-biologie,
R Bakir, and
B Chanu, and
J Rouffy
December 1955,
Prensa medica argentina,
R Bakir, and
B Chanu, and
J Rouffy
January 1988,
Annales de gastroenterologie et d'hepatologie,
R Bakir, and
B Chanu, and
J Rouffy
December 1969,
Minerva anestesiologica,
R Bakir, and
B Chanu, and
J Rouffy
April 1968,
Minerva medica,
R Bakir, and
B Chanu, and
J Rouffy
August 1958,
Jornal do medico,
R Bakir, and
B Chanu, and
J Rouffy
January 1958,
Gazeta medica portuguesa,
